Purification of antimicrobial factors from human cervical mucus

Research Center of Medical Science, Guangdong Provincial People's Hospital, Guangzhou 510080, and Research Unit of Infection and Immunity, West China Medical Center, Sichuan University, Chengdu, People's Republic of China.
Human Reproduction (Impact Factor: 4.59). 08/2007; 22(7):1810-5. DOI: 10.1093/humrep/dem128
Source: PubMed

ABSTRACT The aim of this study was to separate bactericidal proteins from healthy female cervical mucus.
Cervical mucus was collected and dissolved in 1% acetic acid. The antimicrobial activity of acid-soluble extracts was detected by gel overlay assay against Escherichia coli ATCC 43827. The extracts showed considerable amount of antibacterial activity with a clearly visible band. The bactericidal band was purified by reverse-phase high performance liquid chromatography and the antibacterial activity of the eluate was examined using radial diffusion assay.
Two antimicrobial proteins were purified and were further characterized by Tricine sodium dodecyl sulphate-polyacrylamide gel electrophoresis, N-terminal sequencing and matrix-assisted laser desorption ionization time-of-flight mass spectrometry. The proteins were identified as high-mobility group nucleosomal-binding domain 2 (HMG N2) and secretory leukocyte peptidase inhibitor (SLPI). SLPI is an antimicrobial peptide already known in the cervical mucus while HMG N2 in the cervical mucus had not been previously reported. The expression of HMG N2 mRNA was detected in Hela cells and cervical epithelial cells by RT-PCR. Slit hybridization showed abundant amounts of the HMG N2 protein in the cervical mucus.
These results suggest that the expression of HMG N2 and SLPI in the healthy female cervical mucus may be relevant to their immune surveillance and defense against potential pathogens in human reproductive system.

  • [Show abstract] [Hide abstract]
    ABSTRACT: The regulation mechanism for the B cells in the female reproductive tract (FRT) is unclear now. The aim of this study was to analysis the effect of progesterone and mouse endometrium stromal cells (ESCs) on B cells and explore it roles in modulating B cells-mediated immune responses. We primary isolated mouse ESCs from endometrium of BALB/c mice and B cells from spleen cells of BALB/c mice, and then constructed these two kind of cells co-culture system, and treated with or without progesterone. We found that both treatment with progesterone and co-culture with ESCs reduced the expression of co-stimulatory molecules CD80 and CD86 on mouse B cells from spleen cells. In addition, the expression of CD138 (syndecan-1) on B cells was increased after co-culture with ESCs, however, progesterone could partly reduce this effect. Unlike progesterone, ESCs alone promoted the proliferation and stimulated the secretion level of antibodies IgG and IgA of B cells. Our current results progesterone and ESCs could inhibit the activation of B cells through deceasing CD80 and CD86 expression, regulated the differentiation status of B cells by up-regulating the expression of CD138 together, and might further inhibit the antigen presentation function of B cells, which is beneficial to the establishment of fertilization and pregnancy. In addition, ESCs also promoted the proliferation and antibody secretion, which might participate in the resisting infections during non pregnancy and pregnancy.
    International journal of clinical and experimental pathology 01/2013; 7(1):123-33. · 1.78 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Mucosal immunity consists of innate and adaptive immune responses which can be influenced by systemic immunity. Despite having been the subject of intensive studies, it is not fully elucidated what exactly occurs after HIV contact with the female genital tract mucosa. The sexual route is the main route of HIV transmission, with an increased risk of infection in women compared to men. Several characteristics of the female genital tract make it suitable for inoculation, establishment of infection, and systemic spread of the virus, which causes local changes that may favor the development of infections by other pathogens, often called sexually transmitted diseases (STDs). The relationship of these STDs with HIV infection has been widely studied. Here we review the characteristics of mucosal immunity of the female genital tract, its alterations due to HIV/AIDS, and the characteristics of coinfections between HIV/AIDS and the most prevalent STDs.
    BioMed Research International 01/2014; 2014:20. DOI:10.1155/2014/350195 · 2.71 Impact Factor